ClinicalTrials.Veeva

Menu

Clinical and Pathologic Studies in Neuroendocrine Tumors

Stanford University logo

Stanford University

Status

Withdrawn

Conditions

Neuroendocrine Tumors
Carcinoid Tumor

Treatments

Procedure: urine sample
Procedure: blood sample draw

Study type

Observational

Funder types

Other

Identifiers

NCT00657332
98132
IRB-8988
END0005
NCT00657332

Details and patient eligibility

About

This research involves the study of neuroendocrine tumors in order to better understand how the disease grows and spreads. This study requires will use tissue collected from from biopsies performed during your regular medical care (i.e. tissue leftover after your diagnosis has been made) and/or blood and urine samples. This study may lead to the development of special materials that could be used, in the future, to treat neuroendocrine tumors or to follow the response of neuroendocrine tumors to treatment

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:- Patients are eligible if they have a histologically proven neuroendocrine tumor and are 18 years of age or older

  • Ability to understand and the willingness to sign a written informed consent document. Exclusion Criteria:None

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems